Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis
暂无分享,去创建一个
A. Bonder | B. Saberi | V. Patwardhan | B. Ferrigno | R. Barba | D. Goyes | Leandro Sierra | Wilfor Diaz | Bryan Ferrigno
[1] J. Pomposelli,et al. Survival Benefit of Living-Donor Liver Transplant , 2022, JAMA surgery.
[2] K. Zieniewicz,et al. Long‐term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] T. Cotter,et al. Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] A. Israni,et al. OPTN/SRTR 2019 Annual Data Report: Liver , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] P. Thuluvath,et al. Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics , 2020, PloS one.
[6] S. Alexopoulos,et al. Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database , 2020, Clinical transplantation.
[7] T. Karlsen,et al. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities , 2020, Journal of Gastroenterology.
[8] S. Nundy,et al. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation. , 2020, Journal of clinical and experimental hepatology.
[9] G. Gores,et al. An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort , 2020, Journal of Gastroenterology.
[10] A. Bonder,et al. Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases , 2019, Journal of clinical gastroenterology.
[11] N. Chandok,et al. Primary sclerosing cholangitis: diagnostic and management challenges , 2017, Clinical and experimental gastroenterology.
[12] A. Lok,et al. Recurrent primary sclerosing cholangitis in the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[13] Pedro M. Baptista,et al. How important is donor age in liver transplantation? , 2016, World journal of gastroenterology.
[14] J. Emond,et al. Defining long-term outcomes with living donor liver transplantation in North America. , 2015, Annals of surgery.
[15] B. French,et al. Superior survival using living donors and donor‐recipient matching using a novel living donor risk index , 2014, Hepatology.
[16] S. Hohmann,et al. Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012 , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] T. Hong,et al. Outcomes of living donor liver transplantation using elderly donors , 2014, Annals of surgical treatment and research.
[18] Robert M Merion,et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era , 2011, Hepatology.
[19] S. Halpern,et al. Current Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangitis , 2011, Transplantation.
[20] N. Kemmer. Ethnic disparities in liver transplantation. , 2011, Gastroenterology & hepatology.
[21] Rajeev Sharma,et al. Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database , 2010, Journal of Gastrointestinal Surgery.
[22] Rajeev Sharma,et al. Comparative Analysis of Outcomes in Living and Deceased Donor Liver Transplants for Primary Sclerosing Cholangitis , 2009, Journal of Gastrointestinal Surgery.
[23] I. Ng,et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma , 2007, The British journal of surgery.
[24] T. Karlsen,et al. Primary sclerosing cholangitis , 2001, The Lancet.
[25] C. Benz,et al. [Primary sclerosing cholangitis]. , 2000, Der Internist.
[26] See Related Editorial on Page X , 2022 .